NCT06018415Completed
Effects of Early and Late Time-restricted Eating on Overweight Adults With Metabolic Syndrome
Source: ClinicalTrials.gov · Last updated 22 Dec 2025
Brief summary (registry, in English)
Investigators aim to compare the effects of early and late time-restricted feeding on overweight adults with metabolic syndrome
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 103 (actual)
- First submitted
- 13 Aug 2023
- Start date
- 7 May 2024
- Primary completion date
- 16 Oct 2024
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Diseases
- Obesity
- NCT number
- NCT06018415
What you commit to
- Study type: Interventional
- Participants enrolled: 103
- From 7 May 2024 to the primary completion date, 16 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Unstable weight (change \> 10% current body weight) for 3 months prior to the study
- Being treated with antibiotics or corticosteroids
Other illness
- History of major diseases or related diseases, such as cancer, inflammatory disease, chronic obstructive pulmonary disease and major adverse cardiovascular event
- Active viral hepatitis, acquired immune deficiency syndrome, syphilis and other sexually transmitted diseases, tuberculosis and other infectious diseases
- Current participate in other weight-management program, current on a prescribed diet for special disease or current on any drugs that effect appetite
Other
- Pregnant or breast-feeding
- Night shift workers
- The researcher deemed it inappropriate to participate in the experimenter.
Who the study is looking for
- Age from 18 to 65 years
- Body mass index (BMI): 24.0-40.0 kg/m2
- Diagnosed with metabolic syndrome (i.e., more than 3 abnormal findings out of 5):
- Waist circumference ≥ 90 cm (men) or ≥ 80 cm (women).
- Elevated triglyceride (TG) (use of lipid-lowering medication is an alternate indicator) ≥ 150 mg/dL (1.7 mmol/L).
- Reduced high-density lipoprotein cholesterol (HDL-c) (use of lipid-lowering medication is an alternate indicator) \< 40 mg/dL (1.0 mmol/L) in males \< 50 mg/dL (1.3 mmol/L) in females.
- Elevated blood pressure (use of antihypertensive medication is an alternate indicator). Systolic blood pressure (SBP) ≥ 130 and/or diastolic blood pressure (DBP) ≥ 85 mmHg.
- Elevated fasting blood glucose (FBG) (used of hypoglycemic medications is an alternate indicator) ≥ 100 mg/dL (5.6 mmol/L).
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| First Affiliated Hospital of Xi'an Jiaotong University Coordinator of this site? Confirm its status | Xi'an | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.